JP2023537515A - 神経切除による肺炎症性疾患の処置 - Google Patents

神経切除による肺炎症性疾患の処置 Download PDF

Info

Publication number
JP2023537515A
JP2023537515A JP2023509395A JP2023509395A JP2023537515A JP 2023537515 A JP2023537515 A JP 2023537515A JP 2023509395 A JP2023509395 A JP 2023509395A JP 2023509395 A JP2023509395 A JP 2023509395A JP 2023537515 A JP2023537515 A JP 2023537515A
Authority
JP
Japan
Prior art keywords
pulmonary
disease
nerve
ablation
inflammatory disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023509395A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537515A5 (https=
Inventor
アレクシス ジー． ナハマ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sorrento Therapeutics Inc
Original Assignee
Sorrento Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorrento Therapeutics Inc filed Critical Sorrento Therapeutics Inc
Publication of JP2023537515A publication Critical patent/JP2023537515A/ja
Publication of JP2023537515A5 publication Critical patent/JP2023537515A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/06—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating caused by chemical reaction, e.g. moxaburners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00434—Neural system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00434—Neural system
    • A61B2018/0044—Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00541—Lung or bronchi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00696—Controlled or regulated parameters
    • A61B2018/00732—Frequency

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Plasma & Fusion (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023509395A 2020-08-11 2021-08-10 神経切除による肺炎症性疾患の処置 Pending JP2023537515A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063064302P 2020-08-11 2020-08-11
US63/064,302 2020-08-11
PCT/US2021/045367 WO2022035840A1 (en) 2020-08-11 2021-08-10 Treating pulmonary inflammatory disease by neural ablation

Publications (2)

Publication Number Publication Date
JP2023537515A true JP2023537515A (ja) 2023-09-01
JP2023537515A5 JP2023537515A5 (https=) 2024-08-09

Family

ID=80247308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509395A Pending JP2023537515A (ja) 2020-08-11 2021-08-10 神経切除による肺炎症性疾患の処置

Country Status (9)

Country Link
US (1) US20230301700A1 (https=)
EP (1) EP4196026A4 (https=)
JP (1) JP2023537515A (https=)
CN (1) CN116744867A (https=)
AU (1) AU2021325879A1 (https=)
CA (1) CA3188689A1 (https=)
IL (1) IL300072A (https=)
MX (1) MX2023001763A (https=)
WO (1) WO2022035840A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150111918A1 (en) 2012-03-08 2015-04-23 Medtronic Ardian Luxembourg S.a.r.l Immune system neuromodulation and associated systems and methods
EP3226795B1 (en) 2014-12-03 2020-08-26 Metavention, Inc. Systems for modulating nerves or other tissue
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060200121A1 (en) * 2005-03-03 2006-09-07 Mowery Thomas M Navigable, multi-positional and variable tissue ablation apparatus and methods
KR101719824B1 (ko) * 2008-05-09 2017-04-04 호라이라 인코포레이티드 기관지나무 치료용 시스템, 어셈블리 및 방법
AU2010319477A1 (en) * 2009-11-11 2012-05-24 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
JP5890828B2 (ja) * 2010-05-14 2016-03-22 ニユーラクシス・エルエルシー 脊椎組織を冷却する方法と装置
WO2012052920A1 (en) * 2010-10-18 2012-04-26 CardioSonic Ltd. Therapeutics reservoir
EP4464374A3 (en) * 2012-11-02 2025-01-15 Neurotronic, Inc. Chemical ablation formulations for various diseases
US9827036B2 (en) * 2012-11-13 2017-11-28 Pulnovo Medical (Wuxi) Co., Ltd. Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
US9855317B2 (en) * 2015-04-27 2018-01-02 Reflex Medical, Inc. Systems and methods for sympathetic cardiopulmonary neuromodulation
IL298314B2 (en) * 2016-04-13 2025-04-01 Univ Nebraska Methods of administration and methods of treating cardiovascular diseases with resiniparatoxin
WO2018125822A2 (en) * 2016-12-28 2018-07-05 Coridea, Llc Apparatus to treat cardiopulmonary disease
CN115666551A (zh) * 2020-03-30 2023-01-31 索伦托药业有限公司 通过施用树脂毒素治疗与covid-19相关的肺部炎性疾病
US11007001B1 (en) * 2020-04-07 2021-05-18 Sonivie Ltd. Devices and methods for reducing parasympathetic nerve activity in patients with a respiratory syndrome

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
日臨麻会誌, vol. 34, no. 5, JPN6025029672, 2014, pages 761 - 768, ISSN: 0005770419 *
神経ブロック, INTERNETARCHIVE: WAYBACK MACHINE, JPN6025029671, ISSN: 0005770418 *

Also Published As

Publication number Publication date
CN116744867A (zh) 2023-09-12
US20230301700A1 (en) 2023-09-28
AU2021325879A1 (en) 2023-04-13
EP4196026A1 (en) 2023-06-21
MX2023001763A (es) 2023-02-22
CA3188689A1 (en) 2022-02-17
IL300072A (en) 2023-03-01
EP4196026A4 (en) 2024-09-04
WO2022035840A1 (en) 2022-02-17

Similar Documents

Publication Publication Date Title
Mazzone et al. Vagal afferent innervation of the airways in health and disease
JP2023537515A (ja) 神経切除による肺炎症性疾患の処置
JP2002518983A (ja) 迷走神経トーンの調整方法
JP2026042884A (ja) レシニフェラトキシンを投与することによるｃｏｖｉｄ－１９と関連する肺炎症性疾患の処置
CN107823195A (zh) R‑氯胺酮在抑郁症急性期治疗中的应用
WO2026001874A1 (zh) 脑卒中的治疗
Pathak et al. Laryngeal chemoreflex in health and disease: a review
AU2013403623A1 (en) 1-di(sec-butyl)-phosphinoyl-pentane (DAPA-2-5) as a topical agent for the treatment of discomfort from non-keratinized stratified epithelial (NKSE) tissue
US20210322510A1 (en) Oxytocin improves treatment of obstructive sleep apnea
CN101548981A (zh) 人参皂苷Rg1、Rh1和Ppt抗认知、学习记忆功能障碍的用途
Muller et al. Tactile stimulation of the oropharynx elicits sympathoexcitation in conscious humans
ES2973546T3 (es) Ester isopropílico de ácido [((1R,2S,5R)-2-isopropil-5-metil-ciclohexanocarbonil)-amino]-acético para el tratamiento de la tos crónica
Marcus et al. Sleep and breathing in children: developmental changes in breathing during sleep
Verma Continuous rate infusion anaesthesia with dexmedetomidinemidazolam-ketamine-lignocaine in dexmedetomidine-butorphanolmidazolam-ketamine anaesthetised dogs
US11446264B2 (en) Memory manipulation via modification of protein kinase C zeta activity
Jensen V2a neurons pattern respiratory muscle activity in health and disease
RU2655763C2 (ru) Фармацевтическая композиция и способ лечения женских сексуальных дисфункций
TW202502342A (zh) 食慾素２受體促效劑用於改善睡眠期間之呼吸功能的用途
US20210290728A1 (en) Use of ST266 to Treat Severe Systemic Inflammation and Post-Acute COVID-19 Syndrome
Khan et al. Effect of Lidocaine Administration into Endotracheal Tube Balloon on Hemodynamics and Intraocular Pressure during Intraoperative Period
Chaithali A Study to Assess the Effect of Pretreatment with Intravenous Palonosetron in Preventing Pain on Propofol Injection
Tanase Adenosine as a neuromodulator of pontine acetylcholine release, antinociception, and arousal
Jeggo 5-HT receptors of brainstem cardio-respiratory neurones
Lalani DEPARTMENT OF CARDIOVASCULAR/RESPIRATORY SCIENCES
CN102552298A (zh) Rh1抗认知、学习记忆功能障碍的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240801

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240801

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20241128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250717

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260113